Clinical Trials Browser

NIH × Interventional × Sulindac × Clear all

NCT00841204 2017-12-26

Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma

Phase 2 Completed

50 enrolled 15 charts

Precancerous Conditions

NCT00335504 2017-02-15

Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia

Phase 2 Completed

85 enrolled 10 charts

GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Rectal Neoplasms

NCT01856322 2015-10-23

Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer

Phase 2 Terminated

3 enrolled 5 charts

Gastrointestinal

Colorectal Neoplasms

NCT00343629 2015-04-28

Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers

Phase NA Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00118365 2015-01-22

Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps

Phase 3 Completed

375 enrolled 27 charts

Precancerous Conditions

NCT00368927 2014-05-23

Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia

Phase 2 Completed

61 enrolled 11 charts

Other neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Precancerous Conditions, Tobacco Use Disorder

NCT00245024 2013-05-03

Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer

Phase 1 Completed

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating